SINGAPORE, SG / / April 9, 2026 / Immortal Dragons, the $40 million purpose-driven longevity fund, announced that its portfolio company Frontier Bio has received the Best Paper ...

Boston biotech Avalyn Pharma filed to go public on Nasdaq to fund trials for its inhaled drugs treating rare lung diseases ...

Implacable follow-up is the strategy that Wasabi CEO David Friend applied to buy the Lyve Cloud business from Seagate ...

For anyone who shops at Canadian Tire and flies WestJet, this is a major upgrade. But even if those brands don’t appeal to ...